GlassScriptPhysician profile
Alexandra K Callan
NPI 1922398312
$39,410.81
in general payments reported to CMS, 2019-2025
25 companies · $16K in 2025
The $16K reported for 2025 was more than what 90% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,035 · 2020: $413 · 2021: $3,675 · 2022: $1,567 · 2023: $2,818 · 2024: $14K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $20K · Travel and Lodging: $6,032 · Food and Beverage: $4,747 · Honoraria: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,441.50 |
| Travel and Lodging | $6,032.01 |
| Food and Beverage | $4,746.80 |
| Honoraria | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $26,861.04 | 2019-2025 | Mako, Gmrs, Aequalis |
| Bone Support INC. | $4,696.43 | 2019-2025 | Ceramentbone Void Filler, Cerament G |
| Onkos Surgical, INC. | $3,241.92 | 2019-2025 | Eleos Limb Salvage System |
| Musculoskeletal Transplant Foundation INC. | $2,160.49 | 2019-2023 | |
| Depuy Synthes Sales INC. | $442.13 | 2021-2025 | Orthovisc, Monovisc, Actis |
| Heron Therapeutics, INC. | $359.04 | 2024-2025 | Zynrelef |
| Smith+Nephew, INC. | $222.37 | 2019-2023 | Evos, Trigen |
| Medical Device Business Services, INC. | $210.84 | 2022-2023 | Endurance, Attune |
| Nuvasive, INC. | $151.32 | 2023 | Reline |
| Sanara Medtech INC. | $146.40 | 2022 | |
| Carbofix Orthopedics INC | $143.54 | 2022-2024 | |
| Daiichi Sankyo INC. | $125.00 | 2019 | |
| Orthofix Medical, INC. | $73.99 | 2023 | Trinity Elite |
| Medtronic, INC. | $72.53 | 2024 | Aquamantys(Tm) |
| Ossur Americas, INC. | $72.00 | 2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Illuminoss Medical, INC. | $64.70 | 2022 | |
| Sanofi-Aventis U.S. LLC | $63.37 | 2019-2023 | |
| Ethicon US, LLC | $49.71 | 2024-2025 | Stratafix, Vistaseal, Echelon; Endopath |
| Biocomposites INC | $45.62 | 2021 | |
| Osteocentric Technologies, INC. | $44.88 | 2024 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Ferring Pharmaceuticals INC. | $41.14 | 2023-2024 | Euflexxa |
| Next Science LLC | $37.75 | 2025 | Xperience, Blastx |
| Bioventus LLC | $32.19 | 2023-2024 | Durolane, Durolane |
| Kerecis Limited | $27.41 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Pixee Medical INC. | $25.00 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Callan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.